EMA: “Too early to consider using a fourth dose of mRNA COVID-19 vaccines”

The European Centre for Disease Prevention and Control (ECDC) and EMA’s COVID-19 task force (ETF) have concluded that it is too early to consider using a fourth dose of mRNA COVID-19 vaccines (Pfizer’s Comirnaty and Moderna’s Spikevax) in the general population.  More...

Preprint: SARS-CoV-2 Omicron – multiple inter-variant recombination events

“By analyzing sequences from a large number of Omicron subvariants, we identified diverse recombination events between two Omicron subvariants and several SARS-CoV-2 variants, suggesting that co-infection and subsequent genome recombination play important roles in the on-going evolution of SARS-CoV-2.  More...

UK wakes up to a new Covid wave amid Russian-style news blackouts

Just two and half weeks since Boris Johnson announced to the UK Houses of Parliament that Britain would be dropping almost all Covid restrictions, the virus has bounced back, and the UK is facing yet another fresh wave of disease and death.  More...